Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept in early Polymyalgia Rheumatica
NCT00524381Phase 3Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Aug 2007
- Primary completion
- Jul 2009
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in polymyalgia rheumatica (PMR) comparing Etanercept with Placebo (2 arms). Primary endpoint: Polymyalgia rheumatica activity score at 14 days. Started Aug 2007; status: completed.
02
Drugs
etanercept
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on NCT00524381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524381.